XML 42 R32.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
SUMMARY OF STOCK-BASED COMPENSATION EXPENSE RECOGNIZED FOR STOCK OPTION AWARDS

The Company has recorded stock-based compensation expense related to the issuance of restricted stock awards in the following line items in the accompanying condensed consolidated statements of operations:

 

   2025   2024 
   Three Months Ended
March 31,
 
   2025   2024 
         
Research and development  $21,250   $21,882 
General and administrative   305,366    260,731 
Total stock-based compensation expense  $326,616   $282,613 
SUMMARY OF OPTION ACTIVITY

The following table summarizes stock option activity under the 2014 Plan and 2024 Plan:

 

   Number of
options
   Weighted-average
exercise price
   Weighted-average
remaining contractual
term (in years)
   Aggregate
intrinsic value
 
Outstanding at December 31, 2024   304,125   $6.95    4.45     
Granted                
Exercised                
Forfeited                
Outstanding at March 31, 2025   304,125   $6.95    4.20     
                     
Vested and exercisable at March 31, 2025   304,125   $6.95    4.20     
SUMMARY OF RESTRICTED STOCK AWARD

The following table summarizes restricted stock award activity under the 2014 Plan and 2024 Plan:

 

    Number of            As of March 31, 2025 
    restricted
stock awards
(RSA)
   Weighted-
average
grant price
   FMV on
grant date
   Vested
number
of RSA
   Unvested
number
of RSA
 
Balance at December 31, 2024    1,326,861   $1.99   $2,636,259    1,072,838    254,023 
Granted    253,398    0.84    212,875    66,658    186,740 
Forfeited    (10,289)   0.81    (8,334)       (10,289)
Balance at March 31, 2025    1,569,970   $2.24   $2,840,800    1,139,496    430,474